Recently there has been a significant resurgence in the use of gene and cell therapies thanks to improving efficiencies and safety of these methodologies. As we described in last week's issue of BioWorld Insight, with a number of gene therapies advancing into later-stage trials, the field has begun to attract significant amounts of both private and public capital investments once again. Read More
Last week, the FDA launched OpenFDA, an initiative to make public FDA data available through an application program interface (API), which allows mobile phone app and web developers to access the data directly and present them on websites and mobile apps. Read More
CHICAGO – To the typical attendee of the American Society of Clinical Oncology (ASCO) annual meeting last week, a shortage of clinical data would not appear to be an obvious or pressing problem. Attending the meeting usually means deciding, at any given moment, which two or three interesting presentations to forego for an even more interesting presentation. Read More
